E Fund Management’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,457
| Closed | -$202K | – | 327 |
|
|
2023
Q1 | $202K | Buy |
3,457
+1,023
| +42% | +$59.8K | 0.01% | 299 |
|
|
2022
Q4 | $124K | Sell |
2,434
-628
| -21% | -$32K | 0.01% | 322 |
|
|
2022
Q3 | $251K | Sell |
3,062
-449
| -13% | -$36.8K | 0.02% | 263 |
|
|
2022
Q2 | $238K | Buy |
3,511
+806
| +30% | +$54.6K | 0.02% | 266 |
|
|
2022
Q1 | $299K | Buy |
2,705
+1,879
| +227% | +$208K | 0.01% | 197 |
|
|
2021
Q4 | $80K | Sell |
826
-542
| -40% | -$52.5K | ﹤0.01% | 292 |
|
|
2021
Q3 | $119K | Buy |
+1,368
| New | +$119K | 0.01% | 257 |
|
|
2021
Q1 | $118K | Buy |
+751
| New | +$118K | 0.01% | 235 |
|